Remicade (Infliximab) Infusion Cost in 2026, and How to Lower It
A single Remicade (infliximab) infusion is commonly billed at $3,000 to $8,000 or more at a hospital, and much less at a doctor’s office or standalone infusion center for the exact same drug and dose. The two biggest levers are where you get infused and switching to a biosimilar, and if you qualify, the maker can provide the drug free.
- Site of care is the single biggest driver. The same infliximab infusion is often billed 2 to 3 times more at a hospital outpatient department than at a physician office, a freestanding infusion center, or through home infusion.
- Infliximab biosimilars (Inflectra, Avsola, Renflexis) are the same class of medicine at a lower price. Ask your prescriber and plan whether one is right for you.
- If you are uninsured or your plan will not cover it, the Johnson & Johnson Patient Assistance Foundation can provide Remicade free to patients who qualify. On Medicare, use a charity copay fund instead.
What an Infliximab Infusion Costs
Infliximab is dosed by body weight (commonly 3 to 10 mg/kg) and billed under J-code J1745, so the drug portion scales with your dose. These are national estimates; your bill depends on dose, site, and plan.
| Where you get it | Typical billed cost per infusion |
|---|---|
| Hospital outpatient department | ~$5,000 to $12,000+ |
| Doctor’s office / infusion center | ~$3,000 to $6,000 |
| Biosimilar (Inflectra, Avsola, Renflexis) | ~20 to 50% less |
| With manufacturer free-drug program | as low as $0 (drug) |
Remicade is typically given every 8 weeks after a loading phase (weeks 0, 2, and 6), so annual cost adds up quickly, which is why the site and biosimilar levers matter so much.
Already got a bill for your Remicade (infliximab) infusion? Check if you were overcharged.
A typical Remicade (infliximab) infusion runs $3,000 to $8,000 without insurance. Enter what you were charged and we will flag it.
Or send us the bill and we will fight it down. 64% of cases reduced.
How to Lower the Cost
Ask to move the infusion to a lower-cost site
If you are stable, ask your prescriber whether your infusions can move from a hospital to an in-network doctor’s office, a freestanding infusion center, or home infusion. This is usually the single biggest saving, for both you and your plan, and does not change the medicine.
Ask about an infliximab biosimilar
Inflectra, Avsola, and Renflexis are FDA-approved biosimilars to Remicade. Many plans prefer them and they cost less. Whether to switch is a decision for you and your prescriber, but it is worth raising.
Use the right assistance for your situation
Uninsured or not covered? The Johnson & Johnson Patient Assistance Foundation can provide Remicade free under an income limit. Commercially insured? A copay card can cut your coinsurance. On Medicare? Use a charity fund like the PAN or HealthWell Foundation. Our help paying for medication tool points you to the right one.
Check the bill for errors, especially the J-code units
Because infliximab is dosed by weight and billed per 10 mg (J1745), a units error can multiply the charge. CareRoute Bill Defense checks the units, drug wastage, facility fees, and network status, and disputes errors, with no fee unless we save you money.
Frequently Asked Questions
How much does a Remicade infusion cost?
A single infliximab infusion is commonly billed at about $3,000 to $8,000 or more, and can exceed $12,000 at a hospital because of the facility fee. The same drug and dose is often roughly half that at a doctor’s office or freestanding infusion center. The drug is dosed by weight, so your exact cost depends on your dose.
Why is my infusion so much more expensive at the hospital?
Hospitals add a facility fee and negotiate higher drug rates, so the identical infliximab infusion is routinely billed 2 to 3 times more in a hospital outpatient department than in a physician office, an infusion center, or at home. If you are stable, ask your prescriber whether the infusion can move to a lower-cost site.
Is a biosimilar as good as Remicade, and is it cheaper?
Infliximab biosimilars (Inflectra, Avsola, Renflexis) are FDA-approved as highly similar to Remicade with no clinically meaningful differences, and they generally cost less. Whether to use one is a decision between you and your prescriber, and many plans prefer them.
Can I get Remicade for free?
If you are uninsured, or insured but your plan will not cover it, and your income is under the program limit, the Johnson & Johnson Patient Assistance Foundation can provide Remicade at no cost. Your prescriber submits the request and the drug ships to your infusion site. Commercially insured patients can use a copay card, and Medicare patients can use independent charity funds.
Will my insurance out-of-pocket maximum cap what I pay?
For in-network, covered care, yes. Once you hit your plan’s out-of-pocket maximum, it covers 100% of remaining in-network covered costs for the year. But an out-of-network site or provider can bill amounts that do not count toward that cap, which is why confirming network status of every party matters.
Related
Sources
- CMS Average Sales Price (ASP) drug pricing files (J1745 infliximab and biosimilar J-codes)
- FDA (infliximab biosimilar approvals: Inflectra, Avsola, Renflexis)
- Health Care Cost Institute and AHA (hospital facility fees and site-of-care differentials)
- Johnson & Johnson Patient Assistance Foundation (eligibility and free-drug program)
Prices are national estimates for 2026 and vary widely by dose, site, and plan. Any change of drug or infusion site is a decision for you and your prescriber. This page is educational and is not medical or financial advice. Last updated August 2026.